Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Clinical trial NCT07468136 · RECRUITING

Trial details

NCT number: NCT07468136
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anaplastic Oligodendroglioma Astrocytoma, IDH-Mutant, Grade 3 Astrocytoma, IDH-Mutant, Grade 4 Diffuse Astrocytoma Glioblastoma, IDH-Wildtype Malignant Glioma

Start date: 2026-06-23
Primary completion: 2030-10-25
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.